Home > Protocol Summaries: Compounds > GSK1018921

Protocol Summaries: GSK1018921

Protocol Summaries for GSK1018921
GSK
Study ID		 Phase Title Status
109731 Phase 1 An adaptive PET study in healthy volunteers using [11C]GSK931145 to establish the relationship of Glycine Transporter 1 occupancy by GSK1018921 to plasma concentrations over time. Completed
110791 Phase 1 A 4-part parallel group, randomized, study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamic effects of repeat doses of GSK1018921 in healthy volunteers and stable patients with schizophrenia and to evaluate its effects on pharmacokinetics of midazolam. Terminated
GT1109727 Phase 1 See Detailed Description Completed

Filter list by: